Monte Rosa Therapeutics’ plan to develop a molecular glue degrader in a wide range of cancers has come unstuck. | Monte Rosa ...

A new UCLA study has found that artificial intelligence could help doctors identify prostate cancer patients most ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

Telomir-1 shows potential in oncology and age-related diseases, with new findings on its role in tumor suppression and ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

Telomir-1 reduced tumor size by 50% in a prostate cancer model and protected against chemotherapy-induced toxicity. Telomir Pharmaceuticals plans to submit an IND application by year-end to ...